ZA804262B - Method of treating vascularization of the eye - Google Patents

Method of treating vascularization of the eye

Info

Publication number
ZA804262B
ZA804262B ZA00804262A ZA804262A ZA804262B ZA 804262 B ZA804262 B ZA 804262B ZA 00804262 A ZA00804262 A ZA 00804262A ZA 804262 A ZA804262 A ZA 804262A ZA 804262 B ZA804262 B ZA 804262B
Authority
ZA
South Africa
Prior art keywords
vascularization
eye
treating
treating vascularization
Prior art date
Application number
ZA00804262A
Other languages
English (en)
Inventor
M Bergamini
C Cooper
Original Assignee
Allergan Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Pharma filed Critical Allergan Pharma
Publication of ZA804262B publication Critical patent/ZA804262B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA00804262A 1979-07-16 1980-07-15 Method of treating vascularization of the eye ZA804262B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/057,608 US4230724A (en) 1979-07-16 1979-07-16 Method of treating vascularization of the eye with Flurbiprofen

Publications (1)

Publication Number Publication Date
ZA804262B true ZA804262B (en) 1981-08-26

Family

ID=22011655

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00804262A ZA804262B (en) 1979-07-16 1980-07-15 Method of treating vascularization of the eye

Country Status (3)

Country Link
US (1) US4230724A (ja)
JP (1) JPS5622730A (ja)
ZA (1) ZA804262B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
JPS5810517A (ja) * 1981-07-13 1983-01-21 Santen Pharmaceut Co Ltd 非ステロイド系消炎剤を主成分とする点眼剤
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPS5929616A (ja) * 1982-08-10 1984-02-16 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
US4439451A (en) * 1983-06-30 1984-03-27 The Upjohn Company Treatment of the blood-brain barrier with flurbiprofen
US5171566A (en) * 1986-05-16 1992-12-15 The Green Cross Corporation Flurbiprofen derivative ophthalmic preparation
JP2764261B2 (ja) * 1987-03-17 1998-06-11 リ−ドケミカル株式会社 外用消炎鎮痛剤
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
WO2002078681A2 (en) * 2001-04-02 2002-10-10 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
US20030143165A1 (en) * 2002-01-25 2003-07-31 Allan Evans NSAID-containing topical formulations that demonstrate chemopreventive activity
WO2005049014A1 (en) * 2003-11-18 2005-06-02 Pharmacia Corporation Cox-2 inhibitors for the treatment or prevention of diabetes-related ocular disorders
WO2005102303A2 (en) * 2004-04-21 2005-11-03 Advanced Ocular Systems Limited Antiprostaglandins for the treatment of ocular pathologies
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
WO2007087609A2 (en) * 2006-01-25 2007-08-02 Aciex, Inc. Formulations and methods for treating dry eye
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
MX2009012645A (es) * 2007-05-24 2010-03-08 Aciex Therapeutics Inc Formulaciones y metodos para tratar el ojo seco.
CN110448530A (zh) * 2018-05-07 2019-11-15 北京蓝丹医药科技有限公司 一种氟比洛芬酯注射液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1091403A (en) * 1964-01-24 1967-11-15 Boots Pure Drug Co Ltd Therapeutically active phenylalkane derivatives
US3865949A (en) * 1973-08-02 1975-02-11 Upjohn Co Process of treatment
US4009283A (en) * 1973-11-07 1977-02-22 The Upjohn Company Antiinflammatory and antithrombotic compositions and method of use

Also Published As

Publication number Publication date
US4230724A (en) 1980-10-28
JPH0114204B2 (ja) 1989-03-10
JPS5622730A (en) 1981-03-03

Similar Documents

Publication Publication Date Title
ZA804262B (en) Method of treating vascularization of the eye
PH19294A (en) Treatment method
GB2058035B (en) Sludge treatment method
GB2066324B (en) Well treatment apparatus
DE2861254D1 (en) Method of treating intraocular lens and the like
DE2861105D1 (en) Method and apparatus for the thermal treatment of yarns
PH20118A (en) Method for the treatment of hyperlemia
ZA801559B (en) Equipment for the treatment of suspensions
GB2029475B (en) Apparatus for the treatment of surfaces
JPS5777009A (en) Method of treating sulfur
GB2044311B (en) Process for the treatment of wood
JPS55152864A (en) Fiber treating agent
GB2077142B (en) Artificial leather and process for producing the same
JPS5653247A (en) Interstitial knitting method
GB2013315B (en) Method of and apparatus for the treatment of laundry
JPS55128000A (en) Treating of broth
JPS5613934A (en) Method of treating xxray picture
GB2079328B (en) Textile treatment process
JPS5651413A (en) Glaucoma treatment
JPS55128068A (en) Fabric treating method
JPS5655142A (en) Fish body treating method
JPS5620684A (en) Fabric treating method
JPS5675136A (en) Xxray picture treating method
JPS55121053A (en) Method of treating end
CS191838B1 (en) Method of treating the block polyetheruretane for sanityry purposes